Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Nevro Corp (NVRO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6605
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nevro Corp (Nevro) is a medical device company that offers products for the treatment of chronic pain. The company develops and commercializes senza spinal cord stimulation system (SCS), an evidence-based neuromodulation platform. Its solution for chronic pain also includes HF10 Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. Nevro also develops high-frequency stimulation technology for chronic pain. The company also conducts clinical and preclinical studies on back and leg pain. The company sells its products through its direct sales force, network of sales agents and independent distributors. Nevro is headquartered in Redwood City, California, the US.

Nevro Corp (NVRO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nevro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nevro Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nevro Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nevro Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Nevro Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nevro Corp, Medical Equipment, Deal Details 10
Venture Financing 10
Nevro Raises US$48 Million In Series C Financing 10
Equity Offering 12
Nevro Raises USD126 Million in Public Offering of Shares 12
Nevro Raises USD145 Million in IPO of Shares 14
Debt Offering 16
Nevro Raises USD150 Million in Public Offering of 1.75% Notes Due 2021 16
Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million 17
Nevro Corp – Key Competitors 19
Nevro Corp – Key Employees 20
Nevro Corp – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Aug 02, 2018: Nevro reports second quarter 2018 financial results 22
Jul 16, 2018: Nevro Announces Preliminary Unaudited Second Quarter 2018 Revenue and Updates Full Year 2018 Revenue Guidance 23
May 07, 2018: Nevro Reports First Quarter 2018 Financial Results 24
Feb 22, 2018: Nevro Reports Fourth Quarter and Full Year 2017 Financial Results and Provides 2018 Outlook 25
Jan 08, 2018: Nevro Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2017 Revenue 26
Nov 06, 2017: Nevro Reports Third Quarter 2017 Financial Results 27
Aug 07, 2017: Nevro Reports Second Quarter 2017 Financial Results 28
Jul 05, 2017: Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update 29
May 08, 2017: Nevro Reports First Quarter 2017 Financial Results 30
Feb 23, 2017: Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook 31
Corporate Communications 32
May 14, 2018: Nevro Recognized as a “Best Place to Work” in the Bay Area 32
Legal and Regulatory 33
Jul 30, 2018: Nevro Announces Update on Patent Litigation 33
Jul 25, 2018: Nevro Announces Patent Litigation Update 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Nevro Corp, Medical Equipment, Key Facts, 2017 2
Nevro Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Nevro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nevro Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Nevro Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nevro Corp, Deals By Market, 2012 to YTD 2018 8
Nevro Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Nevro Raises US$48 Million In Series C Financing 10
Nevro Raises USD126 Million in Public Offering of Shares 12
Nevro Raises USD145 Million in IPO of Shares 14
Nevro Raises USD150 Million in Public Offering of 1.75% Notes Due 2021 16
Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million 17
Nevro Corp, Key Competitors 19
Nevro Corp, Key Employees 20
Nevro Corp, Subsidiaries 21

List of Figures
Nevro Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Nevro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Nevro Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Nevro Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Nevro Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Nevro Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Nevro Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Nevro Corp (NVRO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Active Biotech AB (ACTI)-製薬・医療分野:企業M&A・提携分析
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that undertakes the development and commercialization of pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company has five projects in clinical development of which three have been licensed o …
  • Oxford Performance Materials Inc-医療機器分野:企業M&A・提携分析
    Summary Oxford Performance Materials Inc (OPMI), a subsidiary of Arkema Inc is a chemical company that manufactures thermoplastic polymers. The company’s products include proprietary polyether ketone ketone formulations, additives, complex assemblies, biomedical raw materials, biomedical parts, robo …
  • The Tata Power Co Ltd (TATAPOWER):企業の財務・戦略的SWOT分析
    The Tata Power Co Ltd (TATAPOWER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Infosys Ltd (INFY):企業の財務・戦略的SWOT分析
    Infosys Ltd (INFY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Verbund AG (VER):電力:M&Aディール及び事業提携情報
    Summary Verbund AG (Verbund) is an electricity utility that generates, transmits, trades, and distributes electricity. It generates from renewable energy sources such as hydropower, biomass, wind, and solar power. The company constructs, operates and maintains power plants; trades electricity and ga …
  • Exchange Income Corporation:企業の戦略・SWOT・財務分析
    Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report Summary Exchange Income Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Shantui Construction Machinery Co Ltd:企業の戦略・SWOT・財務情報
    Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shantui Construction Machinery Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Invectys SA-製薬・医療分野:企業M&A・提携分析
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company’s product pipeline includes INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine (UCPVax), a human telomerase peptide-based vaccine; INMAB-1, a monoclonal a …
  • Epsilon Energy Ltd (EPS):企業の財務・戦略的SWOT分析
    Summary Epsilon Energy Ltd (Epsilon) is an oil and gas company that provides exploration, exploitation and development of oil and gas reserves. The company provides projects such as Marcellus shale in northeast Pennsylvania, Bakken Shale and Midale Dolomite in Saskatchewan, among others. It operates …
  • Symbiomix Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Symbiomix Therapeutics LLC (Symbiomix) is a drug development company that offers development and commercialization of novel medicines. The company offers SYM-1219, for the treatment of several serious infections in women including bacterial vaginosis. Its SYM-1219 contains secnidazole, nitro …
  • Phoenix Petroleum Philippines Inc (PNX):企業の財務・戦略的SWOT分析
    Summary Phoenix Petroleum Philippines Inc (PNX) is an independent oil and gas company that distributes petroleum products and lubricants. The company provides automotive fuels, biodiesel, gasoline and aviation fuels, among others. It offers services such as trading of refined petroleum products and …
  • Apollo Education Group Inc:企業の戦略的SWOT分析
    Apollo Education Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • OPG Power Ventures Plc (OPG):企業の財務・戦略的SWOT分析
    OPG Power Ventures Plc (OPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Larsen & Toubro Limited:企業の戦略・SWOT・財務情報
    Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report Summary Larsen & Toubro Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mahagenco:企業の戦略的SWOT分析
    Mahagenco - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Kian Joo Can Factory Berhad:戦略・SWOT・企業財務分析
    Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report Summary Kian Joo Can Factory Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MLP SE (MLP):企業の財務・戦略的SWOT分析
    MLP SE (MLP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Valneva SE:企業のM&A・事業提携・投資動向
    Valneva SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Valneva SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • The Walter and Eliza Hall Institute of Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary The Walter and Eliza Hall Institute of Medical Research (WEHI), a subsidiary of Melbourne Medical School The University of Melbourne is a medical research institute that conducts clinical research, and offers educational and contract research services. The institute develops therapeutics for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆